- We are the Pharma Journal directory
The first regulatory approvals for a CRISPR-based medicine in the UK and EU marked a turning point for genomic medicine and set expectations for oncology....
Cathepsin B (CTSB) is a lysosomal cysteine protease that plays a key role in protein turnover, antigen processing, and immune regulation. It is widely expressed...
Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half...
For patients living with blood cancer or a severe blood disorder, a stem cell transplant is often the turning point between decline and recovery. Yet...
Human gene editing sits at a pivotal point in modern medicine. Its capacity to change DNA with precision has moved from conjecture to clinical practice,...
Artificial intelligence is moving from pilot projects to practical tools across the NHS. The policy direction is clear, with a shift to community-based care and...
The rise of online pharmacy services has redrawn the UK medicines landscape in less than a decade. Digital ordering, remote prescribing, and courier fulfilment now...
]In today’s fast-evolving healthcare and pharmaceutical industries, precision and reliability are non-negotiable. From hospitals and research laboratories to biotech companies and pharmaceutical manufacturers, one of...
Prolapse describes structural descent caused by failure of regular anatomical support. Pelvic organ prolapse is an organ herniation into or beyond the vagina driven by...
Huntington’s disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or...